General Electric (GE) Healthcare Unit to Invest $1B in Cancer Fighting Initiatives

GE Healthcare, the health business of General Electric (NYSE: GE), reports it plans to invest $1 billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging capabilities, as well as its world-class technologies for the manufacture of biopharmaceuticals and for cancer research.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• The West Can't Process Enough of This Critical Metal, and the Gap Doesn't Close by 2030
• Space-Eyes names four directors ahead of planned Nasdaq listing
• WiMi proposes quantum convolutional neural network for data tasks